Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 24, 2026
Bloom Energy (BE) vs Oracle (ORCL): Two Sides of the AI Infrastructure Story

Bloom Energy (BE) vs Oracle (ORCL): Two Sides of the AI Infrastructure Story

Key Takeaways

  • Two different AI plays: BE sells on-site fuel-cell power for data centers, while ORCL builds the cloud infrastructure and databases those facilities run on.
  • Momentum gap: BE has delivered triple-digit gains over the past year on surging AI power demand, whereas ORCL has fallen sharply from its record high despite strong revenue growth.
  • Scale and maturity differ: ORCL is a roughly $437 billion enterprise software and cloud giant, while BE is a much smaller, high-beta growth company in the energy transition space.
  • Risk profiles diverge: BE faces valuation and volatility risk after a historic rally; ORCL faces capital intensity, rising debt, and customer concentration tied to its massive backlog.
  • Unexpected overlap: Oracle was among the early hyperscaler customers to adopt Bloom Energy's on-site power, linking the two companies' AI narratives directly.

Setting the Context for These AI Exposures

Investors looking at the artificial intelligence build-out often face two very different avenues for exposure. BE, Bloom Energy, supplies solid-oxide fuel cells that generate on-site electricity for power-hungry data centers. ORCL, Oracle, provides the databases and cloud infrastructure that consume that power. This comparison matters for traders weighing a high-growth, high-volatility energy name against an established technology leader navigating a capital-intensive shift. Understanding their relative performance, business models, and positioning helps clarify where momentum, stability, and risk stand across the AI infrastructure value chain. I also checked sector peers using Tickeron’s AI Screener to see how these two stack up.

Bloom Energy Overview and Recent Performance

Bloom Energy designs, manufactures, and installs solid-oxide fuel cell systems that convert natural gas, biogas, or hydrogen directly into electricity without combustion. Its on-site power servers have become increasingly tied to the AI data center build-out, where they can deliver power in months rather than the years an interconnection to the grid can require.

Recent market activity has been exceptionally strong for BE. The company recently posted its first $1 billion revenue quarter, up roughly 166% year over year, and raised its full-year revenue outlook to a range of $3.9 billion to $4.2 billion. Sentiment has been further supported by an expanded financing partnership with Brookfield Asset Management, now valued at up to $25 billion, and a backlog approaching $20 billion. Shares have climbed sharply over the past year and were recently added to the S&P 500, although the stock's elevated beta and premium valuation have also invited profit-taking during recent weeks. From what I see, the trend consistency here stands out.

Oracle Overview and Recent Performance

Oracle is a leading provider of enterprise software, database technology, and cloud infrastructure. In recent quarters, its Oracle Cloud Infrastructure (OCI) segment has become the focal point of the company's growth story, renting computing power increasingly used for AI training and inference workloads.

Oracle's recent results show accelerating demand alongside mounting execution questions. In its latest fiscal quarter, total revenue rose about 30% and cloud infrastructure revenue climbed more than 120%, while remaining performance obligations reached roughly $664 billion. Despite this, ORCL shares have declined considerably from their prior record high. Investors have focused on the cost of serving that backlog: capital expenditures more than doubled in the latest fiscal year, free cash flow turned deeply negative, and the company has raised substantial debt and equity to fund its data center build-out. A large, multiyear AI capacity agreement with OpenAI also introduces customer concentration risk that the market has been weighing. I reviewed the backlog dynamics with Tickeron’s AI Trend Prediction Engine to put the numbers in context.

Head-to-Head Comparison

At the business-model level, BE and ORCL sit on opposite sides of the AI infrastructure stack. Bloom Energy is an industrial hardware and energy company selling physical power systems, while Oracle is a software and cloud services leader monetizing compute, data, and applications.

Their growth drivers are distinct but complementary. BE benefits from the grid interconnection bottleneck, offering speed-to-power that hyperscalers and neocloud operators value. ORCL benefits from surging demand for AI computing capacity, reflected in rapid OCI growth and a record backlog. Notably, the two stories intersect: Oracle was an early hyperscaler adopter of Bloom Energy's on-site power systems.

The risk profiles could hardly be more different in character. BE's primary near-term risk is valuation and volatility after an enormous run, given its premium forward earnings multiple and high beta. ORCL's risks center on capital discipline, negative free cash flow, rising debt, and dependence on a small number of very large AI contracts. Sector exposure also diverges: BE sits within the energy and industrial transition, while ORCL is firmly in technology infrastructure.

Market sentiment reflects these contrasts. Momentum has favored BE recently, while ORCL trades well below its highs even as its revenue growth remains strong. In short, BE offers higher-octane, higher-volatility exposure to the AI power theme, whereas ORCL offers a larger, more diversified franchise whose AI opportunity is tempered by financing and execution concerns.

AI-Driven Perspective on the Pair

Based on observable factors, Tickeron's AI would likely favor BE in the current environment on the strength of its trend consistency and positive momentum. The stock's sustained uptrend, expanding revenue, improving profitability, and clear catalysts such as its financing partnership and S&P 500 inclusion present a more straightforward trend-following setup. By contrast, ORCL shows stronger fundamental scale and contracted demand but is currently contending with negative price momentum, financing friction, and execution uncertainty around its capital-intensive build-out. AI-driven systems that weight trend and momentum would therefore be more inclined to favor BE in the near term, while acknowledging that ORCL's valuation and backlog could support a rotation if its cash-flow and execution picture stabilizes. As with any probabilistic assessment, this is a relative, condition-dependent read rather than a definitive outcome.

Using Tickeron’s AI Trading Bots for Systematic Views

In my research process, I frequently turn to Tickeron’s AI Trading Bots to evaluate strategies across names like these. The platform hosts hundreds of bots with performance histories, trading styles, and timeframes, allowing comparison of approaches that match different risk tolerances and market conditions. This helps refine perspectives without replacing individual analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ORCL, BE

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ORCL in upward trend: 10-day moving average crossed above 50-day moving average on August 19, 2026

The 10-day moving average for ORCL crossed bullishly above the 50-day moving average on August 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

ORCL moved above its 50-day moving average on September 16, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCL advanced for three days, in 227 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 189 of 287 cases where ORCL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ORCL as a result. In 45 of 68 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.

The Moving Average Convergence Divergence Histogram (MACD) for ORCL turned negative on September 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 23 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

ORCL broke above its upper Bollinger Band on September 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 24 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.299) is normal, around the industry mean (20.388). P/E Ratio (23.386) is within average values for comparable stocks, (157.795). Projected Growth (PEG Ratio) (0.833) is also within normal values, averaging (3.678). Dividend Yield (0.013) settles around the average of (0.004) among similar stocks. P/S Ratio (5.858) is also within normal values, averaging (103.889).

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. ORCL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 79 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), Twilio (NYSE:TWLO), NetApp (NASDAQ:NTAP), MongoDB (NASDAQ:MDB), Okta (NASDAQ:OKTA), Zscaler (NASDAQ:ZS).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.27B. The market cap for tickers in the group ranges from 48.8K to 3.72T. MSFT holds the highest valuation in this group at 3.72T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was -0%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 28%. AIXC experienced the highest price growth at 73%, while HUBC experienced the biggest fall at -47%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was 28% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 70
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 91
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
ORCL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of a diversified line of business software products

Industry ComputerCommunications

Industry
Packaged Software
Address
2300 Oracle Way
Phone
+1 737 867-1000
Employees
141000
Web
https://www.oracle.com
Interact to see
Advertisement
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Bloom Energy (BE) vs Oracle (ORCL): Two Sides of the AI Infrastructure Story